Transaminase concentrations cannot separate non-alcoholic fatty liver and non-alcoholic steatohepatitis in morbidly obese patients irrespective of histological algorithm

  • \(\bf Background:\) In current general practice, elevated serum concentrations of liver enzymes are still regarded as an indicator of non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH). In this study, we analyzed if an adjustment of the upper limit of normal (ULN) for serum liver enzymes can improve their diagnostic accuracy. \(\bf Methods:\) Data from 363 morbidly obese patients (42.5 \(\pm\) 10.3 years old; mean BMI: 52 \(\pm\) 8.5 kg/m\(^{2}\)), who underwent bariatric surgery, was retrospectively analyzed. NAFL and NASH were defined histologically according to non-alcoholic fatty liver activity score (NAS) and according to steatosis activity fibrosis (SAF) score for 2 separate analyses, respectively. \(\bf Results:\) In 121 women (45%) and 45 men (46%), elevated values for at least one serum parameter (ALT, AST, \(\gamma\)GT) were present. The serum concentrations of ALT (\(\it p\) < 0.0001), AST (\(\it p\) < 0.0001) and \(\gamma\)GT (\(\it p\) = 0.0023) differed significantly between NAFL and NASH, irrespective of the applied histological classification method. Concentrations of all 3 serum parameters correlated significantly positively with the NAS and the SAF score, with correlation coefficients between 0.33 (ALT/NAS) and 0.40 (\(\gamma\)GT/SAF). The area under the curves to separate NAFL and NASH by liver enzymes achieved a maximum of 0.70 (ALT applied to NAS-based classification). For 95% specificity, the ULN for ALT would be 47.5 U/L; for 95% sensitivity, the ULN for ALT would be 17.5 U/L, resulting in 62% uncategorized patients. \(\bf Conclusion:\) ALT, AST, and γGT are unsuitable for non-invasive screening or diagnosis of NAFL or NASH. Utilizing liver enzymes as an indicator for NAFLD or NASH should generally be questioned.

Download full text files

Export metadata

Additional Services

Share in Twitter Search Google Scholar
Metadaten
Author:Peter LemmerGND, Nicole SelbachGND, Theodor BaarsGND, Mustafa Porsch-ÖzcürümezORCiDGND, Dominik HeiderORCiDGND, Ali E. CanbayORCiDGND, Jan-Peter SowaORCiDGND
URN:urn:nbn:de:hbz:294-93916
DOI:https://doi.org/10.1159/000519317
Parent Title (German):Digestive diseases
Publisher:Karger
Place of publication:Basel
Document Type:Article
Language:English
Date of Publication (online):2022/10/27
Date of first Publication:2021/09/01
Publishing Institution:Ruhr-Universität Bochum, Universitätsbibliothek
Tag:Alanine-aminotransferase; Aspartate-aminotransferase; Gamma-glutamyltransferase; Liver; Liver enzymes; NAFLD; NAFLD activity Score; Non-invasive prediction; Obesity; SAF score
Volume:40
Issue:5
First Page:644
Last Page:653
Note:
Dieser Beitrag ist aufgrund einer konsortialen Lizenz frei zugänglich.
Institutes/Facilities:Knappschaftskrankenhaus Bochum, Medizinische Klinik
Dewey Decimal Classification:Technik, Medizin, angewandte Wissenschaften / Medizin, Gesundheit
open_access (DINI-Set):open_access
Licence (German):License LogoKonsortiale Lizenz